GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnamed Holdings Corp (XCNQ:DMED) » Definitions » EV-to-EBITDA

Diagnamed Holdings (XCNQ:DMED) EV-to-EBITDA : -2.60 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Diagnamed Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Diagnamed Holdings's enterprise value is C$2.74 Mil. Diagnamed Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.05 Mil. Therefore, Diagnamed Holdings's EV-to-EBITDA for today is -2.60.

The historical rank and industry rank for Diagnamed Holdings's EV-to-EBITDA or its related term are showing as below:

XCNQ:DMED' s EV-to-EBITDA Range Over the Past 10 Years
Min: -17.13   Med: 0   Max: 2.08
Current: -2.6

During the past 3 years, the highest EV-to-EBITDA of Diagnamed Holdings was 2.08. The lowest was -17.13. And the median was 0.00.

XCNQ:DMED's EV-to-EBITDA is ranked worse than
100% of 463 companies
in the Healthcare Providers & Services industry
Industry Median: 12.62 vs XCNQ:DMED: -2.60

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), Diagnamed Holdings's stock price is C$0.04. Diagnamed Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.022. Therefore, Diagnamed Holdings's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Diagnamed Holdings EV-to-EBITDA Historical Data

The historical data trend for Diagnamed Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnamed Holdings EV-to-EBITDA Chart

Diagnamed Holdings Annual Data
Trend Sep21 Sep22 Sep23
EV-to-EBITDA
- - -2.07

Diagnamed Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.16 -2.06 -3.30 -2.07 -1.84

Competitive Comparison of Diagnamed Holdings's EV-to-EBITDA

For the Health Information Services subindustry, Diagnamed Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnamed Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnamed Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Diagnamed Holdings's EV-to-EBITDA falls into.



Diagnamed Holdings EV-to-EBITDA Calculation

Diagnamed Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2.737/-1.052
=-2.60

Diagnamed Holdings's current Enterprise Value is C$2.74 Mil.
Diagnamed Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Diagnamed Holdings  (XCNQ:DMED) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Diagnamed Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.04/-0.022
=At Loss

Diagnamed Holdings's share price for today is C$0.04.
Diagnamed Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.022.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Diagnamed Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Diagnamed Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnamed Holdings (XCNQ:DMED) Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Diagnamed Holdings Corp is engaged in developing a platform of software-based prescription digital therapeutic products (PDT Products) with the potential to improve early detection of neurological disorders, overall patient health and lower healthcare costs. Its product includes BrainYear and BrainTremor.
Executives
Fabio Chianelli Director, Senior Officer

Diagnamed Holdings (XCNQ:DMED) Headlines

No Headlines